CClinicalTrials.gg
CompletedNCT03150615Updated Jul 12, 2019

Enteral Nutrition After Pancreaticoduodenectomy

An interventional study of Early enteral nutrition and Saline in Cancer of Pancreas, Cancer of Duodenum and Ampulla of Vater Cancer, sponsored by Nanjing Medical University. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-07-12.

Sponsored by Nanjing Medical University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Pancreaticoduodenectomy (PD) is the treatment of choice for resectable periampullary cancer. PD is still associated with a relatively a high incidence of delayed gastric emptying. And, there are no acknowledged strategies to avoid DGE. Several feeding strategies have been investigated to cope with this problem. However, there is still no consensus concerning the best nutrition support method after pancreaticoduodenectomy. The purpose of this study is to determine the effect of nutrition support methods on DGE after pancreaticoduodenectomy: early enteral nutrition or total parenteral nutrition.

Patients undergoing pancreatoduodenectomy will be randomized to receive early enteral nutrition (EN group), or Saline administration (Saline group), or oral intake only (Natural control). The EN group will receive standard enteral diet administered through a nasojejunal tube. Enteral nutrition will be started on the 1st postoperative day and increased daily by 20-40 ml up to the estimated level. The Saline group will receive saline administered through a nasojejunal tube beginning from the 1st postoperative day. Oral intake will not be restricted in all three group.

02

Conditions studied

  • Cancer of Pancreas
  • Cancer of Duodenum
  • Ampulla of Vater Cancer
  • Cholangiocarcinoma
03

In context

Cholangiocarcinoma

914 studies on the registry are indexed under Cholangiocarcinoma; 286 are open to participants now.

This study's enrollment of 120 is above the median of 50 across 687 interventional studies indexed under Cholangiocarcinoma.

Browse Cholangiocarcinoma studies →

Lead sponsor

Nanjing Medical University is the lead sponsor of 169 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Patients underwent selective pancreaticoduodenectomy Patients ≥18 years old and ≤80 years old Having given written informed consent

Exclusion criteria

Exclusion Criteria:

Previous gastric resection or intestinal reconstruction Preoperative complete parenteral or enteral feeding ASA score ≥4 Pregnant women Severe malnutrition Patient who cannot give written informed consent.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Early enteral nutrition

    Nasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.

    Other: Early enteral nutrition · Device: nasojejunal tube insertion · Other: Oral intake

  • Placebo comparator
    Saline Group

    Nasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.

    Other: Saline · Device: nasojejunal tube insertion

  • Other
    ERAS Group

    Nasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.

    Device: nasojejunal tube insertion · Other: Oral intake

Interventions

  • OtherEarly enteral nutrition

    Naso-jejunal tube will be placed intraoperatively. The distal end of the feeding tube would be placed at 30 cm distal to Treitz ligament. Standard enteral diet, administered through a nasojejunal tube, is started on the 1st postoperative day and increased daily by 20-40 ml up to the estimated level. After PD, enteral nutrition liquid regimen will be used step by step from postoperative day 1 to postoperative day 7.Patients are targeted to receive calories for 25 kcal/kg/day. Meanwhile, oral food intake was not restricted.

  • OtherSaline

    Naso-jejunal tube will be placed intraoperatively. The distal end of the feeding tube would be placed at 30 cm distal to Treitz ligament. After PPPD,Only Normal Saline were given through nasojejunal tube. Entral nutrition was not administrated. Patients intake food orally at will.

  • Devicenasojejunal tube insertion

    Also known as: Naso-jejunal tube will be placed intraoperatively.

  • OtherOral intake

    Patients was encouraged to drink water on postoperative day 1, to eat liquid diet on postoperative day 2, to eat semi-solid on postoperative day 3, to eat solid food on postoperative day 4.

06

What researchers measure

Primary outcomes

  1. Incident rate of delayed gastric emptying

    DGE represents the inability to return to a standard diet by the end of the first postoperative week and includes prolonged nasogastric intubation of the patient. Three different grades (A,B,and C) were defined based on the impact on the clinical course and on postoperative management by ISGPS.

    Time frame: 30 days

Secondary outcomes

  1. Postoperative hospital stay length

    Time frame: 60 days

  2. Overall morbidity rate

    Time frame: 30 days

  3. Postoperative mortality rate

    Time frame: 30 days

  4. Rehospitalization rate

    Time frame: 60 days

  5. Infectious complications

    Time frame: 30 days

  6. Evaluation of the severity of the complications

    according to classification of Dindo-Clavien

    Time frame: 30 days

  7. Pancreatic fistulas

    evaluation of the occurrence of pancreatic fistulas, grade B and C, in both groups of patients

    Time frame: 30 days

  8. Hemorrhagic complications

    evaluation of the occurrence of hemorrhagic complications, grade B and C, in both groups of patients

    Time frame: 30 days

  9. Maximum Plasma Concentration fasting plasma GLP-1 level

    Fasting plasma concentration GLP-1 level was monitored

    Time frame: Preoperative day 1, Postoperative day 1, Postoperative day 4, Postoperative day 7

07

Study locations

1 site
  • The first affiliated hospital of Nanjing Medical University
    Nanjing, Jiangsu 210029, China
08

References and documents

Publications

  • Shen Y, Jin W. Early enteral nutrition after pancreatoduodenectomy: a meta-analysis of randomized controlled trials. Langenbecks Arch Surg. 2013 Aug;398(6):817-23. doi: 10.1007/s00423-013-1089-y. Epub 2013 May 22. PubMed 23695769 ↗
  • Lu JW, Liu C, Du ZQ, Liu XM, Lv Y, Zhang XF. Early enteral nutrition vs parenteral nutrition following pancreaticoduodenectomy: Experience from a single center. World J Gastroenterol. 2016 Apr 14;22(14):3821-8. doi: 10.3748/wjg.v22.i14.3821. PubMed 27076767 ↗
  • Zhu XH, Wu YF, Qiu YD, Jiang CP, Ding YT. Effect of early enteral combined with parenteral nutrition in patients undergoing pancreaticoduodenectomy. World J Gastroenterol. 2013 Sep 21;19(35):5889-96. doi: 10.3748/wjg.v19.i35.5889. PubMed 24124335 ↗
  • Perinel J, Mariette C, Dousset B, Sielezneff I, Gainant A, Mabrut JY, Bin-Dorel S, Bechwaty ME, Delaunay D, Bernard L, Sauvanet A, Pocard M, Buc E, Adham M. Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC). Ann Surg. 2016 Nov;264(5):731-737. doi: 10.1097/SLA.0000000000001896. PubMed 27429039 ↗
  • Rayar M, Sulpice L, Meunier B, Boudjema K. Enteral nutrition reduces delayed gastric emptying after standard pancreaticoduodenectomy with child reconstruction. J Gastrointest Surg. 2012 May;16(5):1004-11. doi: 10.1007/s11605-012-1821-x. Epub 2012 Jan 19. PubMed 22258876 ↗
  • Liu X, Chen Q, Fu Y, Lu Z, Chen J, Guo F, Li Q, Wu J, Gao W, Jiang K, Dai C, Miao Y, Wei J. Early Nasojejunal Nutrition Versus Early Oral Feeding in Patients After Pancreaticoduodenectomy: A Randomized Controlled Trial. Front Oncol. 2021 Apr 29;11:656332. doi: 10.3389/fonc.2021.656332. eCollection 2021. PubMed 33996579 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03150615
Lead sponsor
Nanjing Medical University
Responsible party
Yi Miao, Prof. (Director of Pancreas Center, Nanjing Medical University) — Principal investigator
First posted
May 12, 2017
Start date
Sep 2016
Primary completion
Dec 2017
Completion
Feb 2018
Last update
Jul 12, 2019

Study contacts

Yi Miao, Prof.
principal investigator · Pancreas Center, The First Affiliated Hospital of Nanjing Medical University
Junli Wu, MD,PhD
study director · Pancreas Center, The First Affiliated Hospital of Nanjing Medical University
Jishu Wei, MD,PhD
principal investigator · Pancreas Center, The First Affiliated Hospital of Nanjing Medical University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion